Cisen Pharmaceutical Hits Day Low of CNY 14.10 Amid Price Pressure

Cisen Pharmaceutical has experienced significant activity today, with the stock declining by 9.44% as it reached an intraday low of CNY 14.10. This performance stands in contrast to the China Shanghai Composite, which fell by 3.05% on the same day. Over the past week, Cisen has shown a slight recovery with a 3.73% increase, while its one-month performance reflects a gain of 9.24%. However, the stock's year-to-date performance remains negative at -18.07%. Financial metrics indicate that Cisen has faced challenges, with net sales for the first nine months declining by 12.88%. The company has reported negative results for the last three consecutive quarters, and its inventory turnover ratio is at a low of 2.15 times. Despite these hurdles, Cisen maintains a return on equity of 7.41% and a price-to-book ratio of 0.94, suggesting a valuation that some may find attractive. The stock's dividend yield stands at 4.30%, providing some income to shareholders amidst the current volatility.